SynDaver announced Tuesday they have started the manufacturing process.
TAMPA, Fla. – A Tampa company is continuing to help with the COVID-19 response. On Tuesday, SynDaver announced it has begun shifting manufacturing resources to alleviate a massive shortage of respirator-type masks in the USA.
James JudgeTampa company begins manufacturing respirators to help with Florida shortage
First nationwide class to be taught Mar. 31 via Facebook Live
TAMPA, Fla. – Students throughout the U.S. will soon have a new online learning option thanks to SynDaver® in Tampa, which announced they will be providing a free weekly instructor-led frog dissection course via Facebook Live, with plans to add more online courses in the future.
James JudgeTampa company to provide free weekly nationwide science lab instruction online in response to COVID-19 school closures
The company’s first patent of 2020 provides protections for its Central Line Simulator, a procedural training device used by specialized physicians to practice skills related to the insertion of central venous access devices.
TAMPA, Fla. – SynDaver, an advanced bio-technology company specializing in the creation of synthetic human and animal simulators for education, medical testing and training, announced today, the U.S. Patent and Trademark Office granted U.S. Patent 10,553,131, which covers the intellectual property of the company’s Central Line Simulation and Training Device.
James JudgeUSPTO grants patent to SynDaver for its central line simulation technology, expanding the company’s patent portfolio to 16
Driven by high demand for their products, particularly in the education sector, SynDaver tripled the company’s sales force in Q4 of 2019, and plans to add 15 new territory sales managers in Q1 of 2020.
TAMPA, Fla. – SynDaver, a leading developer of synthetic human and animal models used for education, surgical simulation and medical device testing, significantly increased the size of their sales team in 2019 and is planning more additions in 2020 to meet rising demands.
James JudgeSynDaver Expands Sales Operations to Address Demand from Education Sector for their Life-Like Synthetic Human and Animal Models
The Tampa-based biotech company has received its second patent of 2019, and its 15th overall, which covers the intellectual property and simulation methodology for its Wearable Chest Tube Medical Skills Trainer
TAMPA, Fla. – SynDaver, an advanced bio-technology company specializing in the creation of synthetic human and animal simulators for medical testing, education and training, announced today that the U.S. Patent and Trademark Office issued U.S. Patent 10,424,226 for the company’s wearable chest tube skills training device.
James JudgeSynDaver awarded 15th patent―the latest is for the company’s wearable chest tube skills trainer